
Please try another search
Radient Pharmaceuticals Corporation engages in the research, development, manufacture, sale, and marketing of medical diagnostic products. It offers Onko-Sure, a proprietary in-vitro diagnostic cancer test, which is used for the detection and/or monitoring of the presence of colon, rectal, lung, stomach, tongue, ovarian, uterine, liver, pancreatic, bladder, brain, esophageal, hematological, breast, prostate, cervical, thyroid, lymphoma, and trophoblast cancers. The company sells its products through distributors to hospitals, clinical laboratories, clinics, and other health care organizations. It operates primarily in the United States, Canada, China, Chile, Europe, India, Korea, Taiwan, Vietnam, and Japan. The company was formerly known as AMDL, Inc. and changed its name to Radient Pharmaceuticals Corporation in September 2009. Radient Pharmaceuticals Corporation was founded in 1988 and is headquartered in Tustin, California.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review